Indaptus Therapeutics Inc... (INDP)

AI Score

Unlock

0.48

-0.02 (-3.26%)

At close: Apr 03, 2025, 3:59 PM

0.49

0.83%

Pre-market: Apr 04, 2025, 05:00 AM EDT

Indaptus Therapeutics Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008
Cash & Equivalents	5.79M	13.36M	9.63M	39.13M	1.64M	9.29M	39.25M	53.39M	16.44M	23.78M	5.8M	3.4M	611.88K	3.3M	4.74M	1.65M	667.2K
Short-Term Investments	n/a	n/a	16.81M	n/a	n/a	770K	1.33M	1.82M	1.85M	7.04M	2.01M	5.15M	3.07M	1.52M	5.09M	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	60.5K	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	638.25K	754.73K	738.25K	16.48K	44.45K	3.72M	5.43M	1.00	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	21.06K	n/a	3.49M	2.03M	478K	721K	782.31K	262.37K	536.44K	886.07K	730.96K	966.82K	122.23K	156.21K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	51.78K	n/a	n/a	n/a
Other Current Assets	831.58K	n/a	80.91K	148.4K	83.55K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.00	n/a	n/a	n/a
Total Current Assets	6.62M	14M	27.24M	40.39M	1.73M	13.74M	43.56M	56.34M	20.67M	33.19M	8.1M	9.3M	4.61M	5.62M	10.82M	1.79M	884.56K
Property-Plant & Equipment	82.17K	173.94K	81.31K	172.89K	1.35K	3.82M	12.23M	8.21M	4.05M	4.09M	4.39M	4.32M	3.16M	3.44M	1.72M	1.5M	1.27M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	720.43K	928.67K	819.56K	189.37K	45.79K	7.54M	17.95M	8.21M	4.05M	4.09M	4.39M	4.38M	3.16M	3.44M	1.72M	1.5M	1.27M
Total Assets	7.34M	14.92M	28.06M	40.58M	1.78M	21.28M	61.51M	64.55M	24.72M	37.28M	12.49M	13.68M	7.77M	9.06M	12.54M	3.29M	2.16M
Account Payables	870.23K	806K	1.38M	2.54M	155.96K	25.17K	2.85M	1.85M	1.15M	615.26K	n/a	381.16K	319.21K	529.58K	470.42K	354.8K	314.54K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	84.16K	n/a	80.49K	n/a	n/a	544K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.94M
Other Current Liabilities	2.44M	1.21M	1.26M	n/a	622.54K	7.31M	4.81M	3.89M	768K	701.87K	1.56M	709.31K	501.73K	462.37K	464.49K	513.99K	485.57K
Total Current Liabilities	3.39M	2.77M	3.43M	4.6M	2.02M	8.34M	7.66M	5.75M	1.92M	1.32M	1.86M	1.42M	918.23K	1.29M	1.03M	926.08K	3.77M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	1.4M	309K	n/a	97K	328.19K	1.16M	2.97M	n/a	n/a	n/a	793.29K	493.78K
Total Long-Term Liabilities	n/a	73.35K	1.46M	72.86K	n/a	1.4M	309K	n/a	97K	328.19K	1.16M	2.97M	n/a	n/a	n/a	793.29K	493.78K
Total Liabilities	3.39M	2.85M	3.43M	4.68M	2.02M	9.74M	7.96M	5.75M	2.02M	1.65M	3.02M	4.39M	918.23K	1.29M	1.03M	1.72M	4.26M
Total Debt	84.16K	175.05K	80.49K	169.33K	n/a	1.34M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.94M
Common Stock	120.14K	84.01K	84.01K	82.59K	19.45K	727K	727K	727K	727K	694.16K	694.09K	656.29K	533.89K	480.42K	439.36K	527.98	529.52
Retained Earnings	-60.44M	-45.42M	-29.99M	-15.67M	-7.96M	-189.42M	-141.82M	-98.28M	-62.63M	-49.61M	-42.82M	-42.42M	-35.02M	-29.68M	-25.92M	-20.43M	-16.85M
Comprehensive Income	n/a	-0.00	96.43K	n/a	n/a	-727K	n/a	-378K	-378K	n/a	577.93K	2.52M	2.11M	2.15M	2.09M	n/a	n/a
Shareholders Equity	3.94M	12.08M	24.63M	35.9M	-237.7K	11.54M	53.55M	58.8M	22.7M	35.63M	9.48M	9.3M	6.85M	7.77M	11.51M	1.57M	-2.1M
Total Investments	n/a	n/a	16.81M	n/a	n/a	770K	1.33M	1.82M	1.85M	7.04M	2.01M	5.21M	3.07M	1.52M	5.09M	n/a	n/a